vs
Axsome Therapeutics, Inc.（AXSM）与Forestar Group Inc.（FOR）财务数据对比。点击上方公司名可切换其他公司
Forestar Group Inc.的季度营收约是Axsome Therapeutics, Inc.的1.4倍（$273.0M vs $196.0M），Forestar Group Inc.净利率更高（5.6% vs -14.6%，领先20.2%），Axsome Therapeutics, Inc.同比增速更快（65.0% vs 9.0%），Axsome Therapeutics, Inc.自由现金流更多（$-18.7M vs $-157.1M），过去两年Axsome Therapeutics, Inc.的营收复合增速更高（61.7% vs -9.6%）
Jazz Pharmaceuticals是一家全球生物制药企业，专注于肿瘤学与神经科学领域的药物研发及商业化。公司2003年在美国加利福尼亚州成立，目前总部位于爱尔兰都柏林，业务覆盖全球多个核心市场。
福雷斯特集团是一家住宅地块开发企业，总部位于得克萨斯州阿灵顿，业务覆盖美国21个州的51个市场。截至2020年12月31日的12个月内，该公司交付了11518块住宅地块，目前在纽约证券交易所上市，自2002年起就是美国规模最大的住宅建筑商D.R. Horton的控股子公司。
AXSM vs FOR — 直观对比
营收规模更大
FOR
是对方的1.4倍
$196.0M
营收增速更快
AXSM
高出56.0%
9.0%
净利率更高
FOR
高出20.2%
-14.6%
自由现金流更多
AXSM
多$138.4M
$-157.1M
两年增速更快
AXSM
近两年复合增速
-9.6%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $196.0M | $273.0M |
| 净利润 | $-28.6M | $15.4M |
| 毛利率 | — | 20.1% |
| 营业利润率 | -13.8% | 7.6% |
| 净利率 | -14.6% | 5.6% |
| 营收同比 | 65.0% | 9.0% |
| 净利润同比 | 61.9% | -6.7% |
| 每股收益（稀释后） | $-0.55 | $0.30 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXSMFOR
| Q4 25 | $196.0M | $273.0M | ||
| Q3 25 | $171.0M | $670.5M | ||
| Q2 25 | $150.0M | $390.5M | ||
| Q1 25 | $121.5M | $351.0M | ||
| Q4 24 | $118.8M | $250.4M | ||
| Q3 24 | $104.8M | $551.3M | ||
| Q2 24 | $87.2M | $318.4M | ||
| Q1 24 | $75.0M | $333.8M |
净利润AXSMFOR
| Q4 25 | $-28.6M | $15.4M | ||
| Q3 25 | $-47.2M | $86.9M | ||
| Q2 25 | $-48.0M | $32.9M | ||
| Q1 25 | $-59.4M | $31.6M | ||
| Q4 24 | $-74.9M | $16.5M | ||
| Q3 24 | $-64.6M | $81.5M | ||
| Q2 24 | $-79.3M | $38.7M | ||
| Q1 24 | $-68.4M | $45.0M |
毛利率AXSMFOR
| Q4 25 | — | 20.1% | ||
| Q3 25 | — | 22.3% | ||
| Q2 25 | — | 20.4% | ||
| Q1 25 | — | 22.6% | ||
| Q4 24 | — | 22.0% | ||
| Q3 24 | — | 23.9% | ||
| Q2 24 | — | 22.5% | ||
| Q1 24 | — | 24.9% |
营业利润率AXSMFOR
| Q4 25 | -13.8% | 7.6% | ||
| Q3 25 | -27.0% | 16.9% | ||
| Q2 25 | -24.5% | 11.2% | ||
| Q1 25 | -46.9% | 11.6% | ||
| Q4 24 | -61.1% | 8.7% | ||
| Q3 24 | -59.8% | 19.7% | ||
| Q2 24 | -89.5% | 16.2% | ||
| Q1 24 | -89.7% | 17.6% |
净利率AXSMFOR
| Q4 25 | -14.6% | 5.6% | ||
| Q3 25 | -27.6% | 13.0% | ||
| Q2 25 | -32.0% | 8.4% | ||
| Q1 25 | -48.9% | 9.0% | ||
| Q4 24 | -63.1% | 6.6% | ||
| Q3 24 | -61.7% | 14.8% | ||
| Q2 24 | -91.0% | 12.2% | ||
| Q1 24 | -91.1% | 13.5% |
每股收益（稀释后）AXSMFOR
| Q4 25 | $-0.55 | $0.30 | ||
| Q3 25 | $-0.94 | $1.70 | ||
| Q2 25 | $-0.97 | $0.65 | ||
| Q1 25 | $-1.22 | $0.62 | ||
| Q4 24 | $-1.54 | $0.32 | ||
| Q3 24 | $-1.34 | $1.59 | ||
| Q2 24 | $-1.67 | $0.76 | ||
| Q1 24 | $-1.44 | $0.89 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $322.9M | $211.7M |
| 总债务越低越好 | — | $793.2M |
| 股东权益账面价值 | $88.3M | $1.8B |
| 总资产 | $689.8M | $3.2B |
| 负债/权益比越低杠杆越低 | — | 0.44× |
8季度趋势，按日历期对齐
现金及短期投资AXSMFOR
| Q4 25 | $322.9M | $211.7M | ||
| Q3 25 | $325.3M | $379.2M | ||
| Q2 25 | $303.0M | $189.2M | ||
| Q1 25 | $300.9M | $174.3M | ||
| Q4 24 | $315.4M | $132.0M | ||
| Q3 24 | $327.3M | $481.2M | ||
| Q2 24 | $315.7M | $359.2M | ||
| Q1 24 | $331.4M | $416.2M |
总债务AXSMFOR
| Q4 25 | — | $793.2M | ||
| Q3 25 | — | $802.7M | ||
| Q2 25 | — | $872.8M | ||
| Q1 25 | — | $872.5M | ||
| Q4 24 | — | $806.8M | ||
| Q3 24 | — | $706.4M | ||
| Q2 24 | — | $706.1M | ||
| Q1 24 | — | $705.7M |
股东权益AXSMFOR
| Q4 25 | $88.3M | $1.8B | ||
| Q3 25 | $73.7M | $1.8B | ||
| Q2 25 | $73.1M | $1.7B | ||
| Q1 25 | $53.2M | $1.6B | ||
| Q4 24 | $57.0M | $1.6B | ||
| Q3 24 | $92.9M | $1.6B | ||
| Q2 24 | $102.9M | $1.5B | ||
| Q1 24 | $144.0M | $1.5B |
总资产AXSMFOR
| Q4 25 | $689.8M | $3.2B | ||
| Q3 25 | $669.3M | $3.1B | ||
| Q2 25 | $639.8M | $3.1B | ||
| Q1 25 | $596.7M | $3.0B | ||
| Q4 24 | $568.5M | $3.0B | ||
| Q3 24 | $561.5M | $2.8B | ||
| Q2 24 | $548.2M | $2.7B | ||
| Q1 24 | $545.7M | $2.6B |
负债/权益比AXSMFOR
| Q4 25 | — | 0.44× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.52× | ||
| Q1 25 | — | 0.53× | ||
| Q4 24 | — | 0.50× | ||
| Q3 24 | — | 0.44× | ||
| Q2 24 | — | 0.47× | ||
| Q1 24 | — | 0.48× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-18.7M | $-157.0M |
| 自由现金流经营现金流 - 资本支出 | $-18.7M | $-157.1M |
| 自由现金流率自由现金流/营收 | -9.6% | -57.5% |
| 资本支出强度资本支出/营收 | 0.0% | 0.0% |
| 现金转化率经营现金流/净利润 | — | -10.19× |
| 过去12个月自由现金流最近4个季度 | $-93.9M | $93.0M |
8季度趋势，按日历期对齐
经营现金流AXSMFOR
| Q4 25 | $-18.7M | $-157.0M | ||
| Q3 25 | $1.0M | $256.3M | ||
| Q2 25 | $-32.4M | $15.8M | ||
| Q1 25 | $-43.4M | $-19.8M | ||
| Q4 24 | $-26.2M | $-450.0M | ||
| Q3 24 | $-18.6M | $119.2M | ||
| Q2 24 | $-30.1M | $-61.7M | ||
| Q1 24 | $-53.5M | $-59.2M |
自由现金流AXSMFOR
| Q4 25 | $-18.7M | $-157.1M | ||
| Q3 25 | $988.0K | $255.6M | ||
| Q2 25 | $-32.4M | $15.0M | ||
| Q1 25 | $-43.7M | $-20.5M | ||
| Q4 24 | $-26.2M | — | ||
| Q3 24 | $-18.7M | $118.4M | ||
| Q2 24 | $-30.2M | $-62.3M | ||
| Q1 24 | $-53.6M | $-59.8M |
自由现金流率AXSMFOR
| Q4 25 | -9.6% | -57.5% | ||
| Q3 25 | 0.6% | 38.1% | ||
| Q2 25 | -21.6% | 3.8% | ||
| Q1 25 | -36.0% | -5.8% | ||
| Q4 24 | -22.1% | — | ||
| Q3 24 | -17.9% | 21.5% | ||
| Q2 24 | -34.6% | -19.6% | ||
| Q1 24 | -71.4% | -17.9% |
资本支出强度AXSMFOR
| Q4 25 | 0.0% | 0.0% | ||
| Q3 25 | 0.0% | 0.1% | ||
| Q2 25 | 0.0% | 0.2% | ||
| Q1 25 | 0.3% | 0.2% | ||
| Q4 24 | 0.0% | 0.0% | ||
| Q3 24 | 0.1% | 0.1% | ||
| Q2 24 | 0.1% | 0.2% | ||
| Q1 24 | 0.1% | 0.2% |
现金转化率AXSMFOR
| Q4 25 | — | -10.19× | ||
| Q3 25 | — | 2.95× | ||
| Q2 25 | — | 0.48× | ||
| Q1 25 | — | -0.63× | ||
| Q4 24 | — | -27.27× | ||
| Q3 24 | — | 1.46× | ||
| Q2 24 | — | -1.59× | ||
| Q1 24 | — | -1.32× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AXSM
暂无分部数据
FOR
| D.R.Horton Inc. | $183.8M | 67% |
| Other | $89.2M | 33% |
